Fate Therapeutics
FATE
#9044
Rank
HK$0.96 B
Marketcap
HK$8.40
Share price
-1.82%
Change (1 day)
-54.62%
Change (1 year)

Fate Therapeutics (FATE) - Net assets

Net assets on the balance sheet as of September 2025 : HK$1.82 Billion

According to Fate Therapeutics 's latest financial reports the company has HK$1.82 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Fate Therapeutics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$2.47 B-14%
2023-12-31$HK$2.87 B-23.9%
2022-12-31$HK$3.78 B-28.57%
2021-12-31$HK$5.29 B77.61%
2020-12-31$HK$2.98 B56.35%
2019-12-31$HK$1.90 B51.69%
2018-12-31$HK$1.25 B108.37%
2017-12-31$HK$0.60 B6.31%
2016-12-31$HK$0.56 B92.41%
2015-12-31$HK$0.29 B34.12%
2014-12-31$HK$0.21 B-44.25%
2013-12-31$HK$0.39 B-196.3%
2012-12-31$-HK$0.41 Billion4.02%
2011-12-31$-HK$0.4 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
HK$10.27 B 463.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$198.22 B 10,782.83%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-HK$1.22 Billion-166.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
HK$14.67 B 705.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$23.37 B 1,183.23%๐Ÿ‡บ๐Ÿ‡ธ USA